G2TT
来源类型Discussion paper
规范类型论文
来源IDDP15512
DP15512 A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development
Lucas Böttcher; Hans Gersbach
发表日期2020-12-03
出版年2020
语种英语
摘要Starting from a general framework for the study of antibiotic-resistance, we introduce a market-based refunding scheme that incentivizes companies to develop antibiotics against resistant bacteria and, in particular, narrow-spectrum antibiotics that target specific resistant bacterial strains. Successful companies can claim a refund from a newly-established antibiotics fund that partially covers their development costs. The refund involves a fixed and variable part. The latter increases with the use of the new antibiotic for resistant strains-the "resistance premium"-and it decreases with the use for non-resistant bacteria-the "non-resistance penalty". We outline how such a refunding scheme can solve the so-called "antibiotics dilemma", which states that new antibiotics against resistant bacteria are of high societal value, but unattractive for companies, since sales are low. We illustrate that the refunding scheme can cope with various sources of R&D uncertainty and we discuss how the antibiotics fund could be financed.
主题Industrial Organization
关键词Antibiotic-resistance - antibiotics dilemma - r&d incentives - refunding scheme - narrow-spectrum antibiotics - r&d uncertainty
URLhttps://cepr.org/publications/dp15512
来源智库Centre for Economic Policy Research (United Kingdom)
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/544514
推荐引用方式
GB/T 7714
Lucas Böttcher,Hans Gersbach. DP15512 A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development. 2020.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Lucas Böttcher]的文章
[Hans Gersbach]的文章
百度学术
百度学术中相似的文章
[Lucas Böttcher]的文章
[Hans Gersbach]的文章
必应学术
必应学术中相似的文章
[Lucas Böttcher]的文章
[Hans Gersbach]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。